Bibliography

Aaby P, Clements CJ. Measles immunization research: a review. Bulletin of the World Health Organization 1989;67:443-448.

Abe T. Nonaka C, Hiraiwa M, Ushijima H, Fujii R. Acute and delayed neurologic reaction to inoculation with attenuated live measles virus. Brain and Development 1985;7:421-423.

Abrahamson HA. Vaccines, poliomyelitis, and the Guillain-Barre syndrome (editorial). Journal of Asthma Research 1976;14:1-4.

Abu Eldan J, Borcic B, Smerdel S. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine. Acta Medica Croatica 1991;45:297-304.

Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M et. al. Comparative study of the reactogenicity and efficacy of different combined vaccines against diphtheria, pertussis and tetanus. Progress in Immunobiological Standardization 1969:3:290-291.

Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M et. al. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus. Journal of Hygiene, Epidemiology, Microbiology, and Immunology 1970;14:88-101.

Adam E, Domorazkova E, Kratochvilova M, Burian V, Janotova J, Drevo M et. al. [The experience with vaccination against measles in Czech districts] Zkusenosti s ockovanim proti spalnickam v ceskych krajich. Ceskoslovenska Pediatrie 1970;25:438-440.

Adam E, Fosenbauerova E, Domorazkova E, Kratochvilova M, Kubatova E, Mares I et. al. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC] Srovnavaci studie spalnickovych vakcin pripravenych z dale atenuovanych kmenangu Schwarz a SEVAC. Ceskoslovenska Pediatrie 1968;23:581-593.

Adams JM. Persistent or slow vital infections and related diseases. Western Journal of Medicine 1975;122:380-393.

Adams JM. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 974, p. 273. Washington, DC: American Society for Microbiology;1992.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Bibliography Aaby P, Clements CJ. Measles immunization research: a review. Bulletin of the World Health Organization 1989;67:443-448. Abe T. Nonaka C, Hiraiwa M, Ushijima H, Fujii R. Acute and delayed neurologic reaction to inoculation with attenuated live measles virus. Brain and Development 1985;7:421-423. Abrahamson HA. Vaccines, poliomyelitis, and the Guillain-Barre syndrome (editorial). Journal of Asthma Research 1976;14:1-4. Abu Eldan J, Borcic B, Smerdel S. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine. Acta Medica Croatica 1991;45:297-304. Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M et. al. Comparative study of the reactogenicity and efficacy of different combined vaccines against diphtheria, pertussis and tetanus. Progress in Immunobiological Standardization 1969:3:290-291. Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M et. al. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus. Journal of Hygiene, Epidemiology, Microbiology, and Immunology 1970;14:88-101. Adam E, Domorazkova E, Kratochvilova M, Burian V, Janotova J, Drevo M et. al. [The experience with vaccination against measles in Czech districts] Zkusenosti s ockovanim proti spalnickam v ceskych krajich. Ceskoslovenska Pediatrie 1970;25:438-440. Adam E, Fosenbauerova E, Domorazkova E, Kratochvilova M, Kubatova E, Mares I et. al. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC] Srovnavaci studie spalnickovych vakcin pripravenych z dale atenuovanych kmenangu Schwarz a SEVAC. Ceskoslovenska Pediatrie 1968;23:581-593. Adams JM. Persistent or slow vital infections and related diseases. Western Journal of Medicine 1975;122:380-393. Adams JM. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 974, p. 273. Washington, DC: American Society for Microbiology;1992.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Adams JM, Brown WJ, Cremer NE, Eberle ED, Fewster ME, Lennette EH. Atypical demyelinating disease. Journal of Neurology, Neurosurgery and Psychiatry 1974;37:874-878. Adams JM, Brown WJ, Eberle ED, Verity A. Vaccinia virus implicated in diffuse demyelinating disease. Proceedings of the Society for Experimental Biology and Medicine 1973; 143:799-803. Adams JM, Francke E, Lillestol M. Poliomyelitis vaccination (letter). New England Journal of Medicine 1977;297:1290-1291. Adams WG, Deaver KA, Cochi SL et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Journal of the American Medical Association 1993;269:221-226. Adenyi-Jones SC, Faden H, Ferdon MB, Kwong MS, Ogra PL. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. Journal of Pediatrics 1992;120:686-689. Adler JB, Mazzotta SA, Barkin JS. Pancreatitis caused by measles, mumps, and rubella vaccine. Pancreas 1991;6:489-490. Adler SP. The effects and side effects of vaccines. Virginia Medical Journal 1982;109:410-411. Advisory Commission on Childhood Vaccines, Martin Smith, Chairman. Vaccine Injury Compensation Program: past, present, and future. June 20, 1991. Unpublished. Afzal MA, Pickford AR, Forsey T, Minor PD. Heterogeneous mumps vaccine. Lancet 1992;340:980-981. Agrawal K, Pandit K, Kannan AT. Single dose tetanus toxoid: a review of trials in India with special reference to control of tetanus neonatorum. Indian Journal of Pediatrics 1984;81:285-295. Aho K, Somer T, Salo OP. Rheumatoid factor and immuno-conglutinin responses following various vaccinations. Proceedings of the Society for Experimental Biology and Medicine 1967;124:229-33. Ahonkhai VI, Lukacs LJ, Jonas LC, Calandra GB. Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein. Vaccine 1991;9(Suppl.):S38-41, S42-43. Ahonkhai VI, Lukacs LJ, Jonas LC, Matthews H, Vella PP, Ellis RW et. al. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. Pediatrics 1990;85(4 Pt 2):676-681. Ahronheim G, Allard M, Forsey T, Rydbeck R, Teuwen D, Yamada A. Mumps associated with trivalent vaccine containing Urabe Am 9 mumps strain (abstract). Program Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 148. Washington, DC: American Society for Microbiology; 1990. Ahronheim GA, Allard M, Forsey T, Rydbeck R, Teuwen DE, Yamada A. Mumps associated with trivalent vaccine containing Urabe Am 9 mumps strain (abstract). Pediatric Research 1991;29:166A. Ajjan N, Bentejac MC. [Anti-mumps vaccination] La vaccination anti-ourlienne. Revue de Pediatric 1985;21:55-61. Ajjan N, Biron G, Bentejac MC. [The dangers of vaccination] Les dangers de la vaccination. Revue Medicale 1980;21:739-750. Ajjan N, Fayet MT, Biron G et. al. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine. Developments in Biological Standardization 1978;41:209-216. Akama K, Yamamoto A. [Side effects of tetanus toxoid. II. Antigenic materials derived from the constituents of the medium for toxoid preparation]. Nippon Saikingaku Zasshi 1969;24:595-601. Akosa AB, All MH, Khoo CT, Evans DM. Angiolymphoid hyperplasia with eosinophilia associated with tetanus toxoid vaccination. Histopathology 1990;16:589-593.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Al-Qudah AA, Shahar E, Logan WJ, Murphy EG. Neonatal Guillain-Barre syndrome. Pediatric Neurology 1988;4:255-256. Albert JM, Ott HJ. Calcifying dermatomyositis following antitetanus vaccination. Archives of Internal Medicine 1983;143:1457-1458. Albrecht P, Lorenz D, Klutch MJ, Vickers JH, Ennis FA. Fatal measles infection in marmosets: pathogenesis and prophylaxis. Infection and Immunity 1980;27:969-978. Albrecht RM. Poliomyelitis from a vaccinee. Lancet 1968;1:1371. Alderslade R, Bellman MH, Rawson NS B., Ross EM, Miller DL. The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team. In: Department of Health and Social Security. Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunization. London: Her Majesty's Stationery Office; 1981. Alexander ER. Landmark perspective: Inactivated poliomyelitis vaccination—issues reconsidered. Journal of the American Medical Association 1984;251:2710-2712. Allen TW. Efficacy of PRP, PRP-D vaccines in children 18 months of age and older. Journal of the American Osteopathic Association 1991;91:323. Allerdist H. [Epidemiologic problems of measles-mumps vaccination] Epidemische Probleme der Masern-Mumpsimpfung. Offentliche Gesundheitswesen 1979;41 (Suppl. 1):51-56. Allerdist H. Neurological complications following measles vaccination. Developments in Biological Standardization 1979;43:259-264. Allerdist H. [Neurological complications following measles virus vaccination: Evaluation of the cases seen between 1971-1977] Uber Zentralnervose Komplikationen nach Masemschutzimpfung: eine Analyse des Hamburger Krankengutes von 1971 bis 1977. Monatsschrift fur Kinderheilkunde 1979;127:23-28. Alter HJ, Scanlon RT, Schechter GP. Thrombocytopenic purpura following vaccination with attenuated measles virus. American Journal of Diseases of Children 1968;115:111-113. Alter M. The epidemiology of Guillain-Barre syndrome. Annals of Neurology 1990;27(Suppl.):S7-S12. Alter MJ, Hadler SC, Margolis HS. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. Journal of the American Medical Association 1988;263:1218-1222. Alves RS, Barbosa ER, Scarf M. Postvaccinal parkinsonism. Movement Disorders 1992;7:178-180. Alvord EC Jr. Incubation period and severity of experimental allergic encephalomyelitis: analogy with swine-flu-vaccine-induced Guillain-Barre syndrome (letter). Annals of Neurology 1986;19:100-101. Alvord EC Jr., Jahnke U, Fischer EH. The causes of the syndromes of Landry (1859) and of Guillain, Barre and Strohl (1916). Revue Neurologique 1987;143:571-579. Ambrosino DM, Lee MY, Chen D, Shamberger RC. Response to Haemophilus influenzae type b conjugate vaccine in children undergoing splenectomy. Journal of Pediatric Surgery 1992;27:1045-1048. Ambrosino DM, Sood SK, Lee MC, Chen D, Collard HR, Bolon DL et al. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants . Pediatric Infectious Disease Journal 1992;11:855-859. American Family Physician. Combining DTP vaccine and H. influenzae type b vaccine. American Family Physician 1992;45:909-910. American Family Physician. New poliovirus vaccine. American Family Physician 1991;43:2270. American Journal of Diseases of Children. Recommendations of the Immunization Practices Advisory Committee (ACIP): mumps prevention. American Journal of Diseases of Children 1989;143:1141-1142.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccine. Pediatrics 1988;81:908-911. American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccines: immunization of children at 15 months of age. Pediatrics 1990;86:794-796. American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update. Pediatrics 1991;88:169-172. American Academy of Pediatrics, Committee on Infectious Diseases. Health guidelines for the attendance in daycare and foster care settings for children infected with human immunodeficiency virus. Pediatrics 1987;79:466-471. American Academy of Pediatrics, Committee on Infectious Diseases. Personal and family history of seizures and measles immunization. Pediatrics 1987;80:741-742. American Academy of Pediatrics, Committee on Infectious Diseases. Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 1964. American Academy of Pediatrics, Committee on Infectious Diseases. Report of the Committee on Infectious Diseases: 22nd edition. Elk Grove Village, IL: American Academy of Pediatrics; 1991. American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Assessment: DTP vaccination. Neurology 1992;42(3 Pt. 1):471-472. Aminova MG, Cheredova NG, Novokreshchenova FA, Atakhanov KA, Shakhmuradova VS. [Clinical reactions in children after the administration of the Leningrad-4 live measles vaccine according to data from Kirghizia] Klinicheskie reaktsii u detei na vvedenie zhivoi korevoi vaktsiny iz shtamma Leningrad-4 po dannym Kirgizii. Trudy Leningradskogo Nauchno-issledovatelskogo Instituta Epidemiologii i Mikrobiologii 1965;28:186-191. Amir J, Liang X, Granoff DM. Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatric Research 1990;27(4 Pt 1):358-364. Amir J, Scott MG, Nahm MH, Granoff DM. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. Journal of Infectious Diseases 1990;162:163-171. Ammundsen E. [Complications of polio vaccination with Sabin vaccine] Komplikationer ved poliovaccinationen med Sabin-vaccine. Fra Sundhedsstyrelsen 1968;4:337-338. Amsel SG, Hanukoglu A, Fried D, Wolyvovics M. Myocarditis after triple immunization. Archives of Disease in Childhood 1986;61:403-405. Anand JK. Multiple factors in leukaemogenesis. British Medical Journal 1972;4:364. Andelman MB, Schwarz A, Spiegelblatt H. Field trials with further attenuated live measles vaccine without gamma globulin. American Journal of Public Health / Nations Health 1966;56:1891-1897. Andersen O, Eeg-Olofsson E. A prospective study of parapareses in western Sweden. Acta Neurologica Scandinavica 1976;54:312-320. Anderson GR, Gottshall RY, Nelsom E, Angela F. Quadruple vaccines containing pertussis and poliomyelitis vaccines. Health Laboratory Science 1978;15:138-43. Anderson P. Antibody responses to H. influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infection and Immunity 1983;39:233-238. Anderson P, Johnston RB Jr., Smith DH. Human serum activities against Haemophilus influenzae, type b. Journal of Clinical Investigation 1972 ;51:31-38. Anderson P, Pichichero M, Edwards K, Porch CR, Insel R. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharideprotein conjugate vaccine. Journal of Pediatrics 1987;111:644-650. Andersson T, Siden A. A clinical study of the Guillain-Barre syndrome. Acta Neurologica Scandinavica 1982;66:316-327.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Andre FE. Control of poliomyelitis by vaccination in Belgium. Reviews of Infectious Diseases 1984;6(Suppl. 2):S419-S423. Andre FE. Poliomyelitis vaccines in Belgium: 20 years of experience. Developments in Biological Standardization 1979;43:187-193. Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. American Journal of Medicine 1989;87(3a):14S-20S. Andre FE, Peetermans J. Effect of simultaneous administration of live measles vaccine on the ''take rate'' of live mumps vaccine. Developments in Biological Standardization 1986;65:101-107. Andre FE, Safary A. Clinical experience with a yeast derived hepatitis B vaccine. In: Zuckerman AJ, ed. Viral Hepatitis and Viral Disease. New York: Alan R Liss; 1988. Andreoni G, Curatolo D, Cervini E, Provvidenza G, Rocchi G, Velli V. [Isolation of poliovirus in poliomyelitic patients vaccinated with Sabin vaccine] Isolamento di virus polio in poliomielitici vaccinati con vaccino Sabin. Giornale di Malattie Infettive e Parassitarie 1966;18:662-663. Andreoni G, Rocchi G. [Etiologic studies in the patients with central nervous system diseases hospitalized in Rome during the period 1964-1970] Indagine eziologica in pazienti con affezioni del sistema nervoso centrale ricoverati a Roma nel periodo 1964-1970. Annali Sclavo 1971;13:291-298. Andrews NC, Baltimore D. Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction. Journal of Virology 1986;58:212-215. Annals of Emergency Medicine. Tetanus immunization recommendations for persons seven years of age and older. Annals of Emergency Medicine 1986;15:1111-1112. Annals of Internal Medicine. Mumps vaccine. Annals of Internal Medicine 1968;68:632-633. Annals of Internal Medicine. Mumps vaccine: recommendation of the Public Health Service Advisory Committee on Immunization Practices, Centers for Disease Control, U.S. Department of Health, Education, and Welfare, Atlanta, Georgia. Annals of Internal Medicine 1978;88:819-820. Annals of Internal Medicine. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Annals of Internal Medicine 1981:95:723-728. Annals of Internal Medicine. Mumps vaccine: recommendation of the Immunization Practices Advisory Committee. Annals of Internal Medicine 1983:98:192-194. Annals of Internal Medicine. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures: recommendation of the Immunization Practices Advisory Committee. Annals of Internal Medicine 1985; 103:896-905. Annunziato D, Kaplan MH, Hall WW, Ichinose H, Lin JH, Balsam D et al. Atypical measles syndrome: pathologic and serologic findings. Pediatrics 1982;70:203-209. Aprile MA, Kadar D, Wilson S. Sensitization of guinea-pigs to measles vaccines. Clinical Experimental Immunology 1969:5:531-539. Arakawa Y. Amaki S, Miyamoto M, Matsuo Y, Honda T, Shikata T. Safety and efficacy of hepatitis B vaccine in hospital personnel. Japanese Journal of Medicine 1986;25:25-33. Araujo OE, Flowers FP et al. Stevens-Johnson syndrome. Journal of Emergency Medicine 1984;2:129-135. Arbeter AM, Arthur JH, Blakeman GJ et. al. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin. Journal of Pediatrics 1972;81:737-741. Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA. Combination measles, mumps, rubella and varicella vaccine. Pediatrics 1986;78(4 Pt. 2):742-747. Arlazoroff A, Bleicher Z, Klein C, Vure E, Lahat E. Gross B et. al. Vaccine-associated contact paralytic poliomyelitis with atypical neurological presentation. Acta Neurologica Scandinavica 1987:76:210-214.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Armenian HK. Case investigation in epidemiology. American Journal of Epidemiology 1991;134:1067-1072. Arnason BG. Neuroimmunology (editorial). New England Journal of Medicine 1987;316:406-408. Arnason BG, Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. In: Syck PJ et al., eds. Peripheral Neuropathy, 3rd edition. W.B. Saunders; 1992. Artbus M. Injections repetees de serum de cheval chez le lapin. Comptes Rendus des Seances de la Societe de Biologie et ses Filiales 1903;55:817-820. Asbury AK. Diagnostic considerations in Guillain-Barre syndrome. Annals of Neurology 1981;9(Suppl.):1-5. Asbury AK. Guillain-Barre syndrome: historical aspects. Annals of Neurology 1990;27(Suppl.):S2-S6. Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barre syndrome. Annals of Neurology 1978;3:565-566. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Annals of Neurology 1992;27(Suppl.):S21-S24. Asbury AK, Gibbs CJ Jr, eds. Autoimmune neuropathies: Guillain-Barre syndrome. Annals of Neurology 1990;27(Suppl.):S1-S79. Ashworth N. Health comment. Health Quarterly Magazine (New Zealand Department of Health) 1988;40:2. Asindi AA, Bell EJ, Browning MJ, Stephenson JB. Vaccine-induced polioencephalomyelitis in Scotland. Scottish Medical Journal 1988;33:306-307. Askerov VF, Piriev GG. [Clinico-immunological reactions to a live measles vaccine of strain L-16 in children suffering from exudative diathesis and bronchial asthma]. Pediatriya 1977;56:32-33. Askerov VF, Sadykhova AN. [Effect of measles infection and measles vaccination on the immunological reactivity in the child] Vliianie korevoi infektsii i protivokorevoi vaktsinatsii na immunologicheskuiu reaktivnost' detskogo organizma. Pediatriia 1968;7:34-39. Assaad FA, Cockburn WC, Perkins FT. The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry. Bulletin of the World Health Organization 1976;53:319-331. Assis JL. Neurological complication of antirabies vaccination in Sao Paulo, Brazil: clinical and therapeutical aspects. Journal of Neurological Sciences 1975;26:593-598. Association for the Study of Infectious Disease. A retrospective survey of the complications of mumps. Journal of the Royal College of General Practitioners 1974;24:552-556. Astabatsian MA, Bolotovskii VM, Gelikman BG, Mikheeva IV. [Reactogenic properties and immunogenicity of measles and mumps vaccines when used by different procedures] Reaktogennye svoistva i immunogennost korevoi i parotitnoi vaktsin pri razlichnoi taktike ikh primenenii. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1986;6:9-15. Aukrust L, Almeland TL, Refsum D, Aas K. Severe hypersensitivity or intolerance reactions to measles vaccine in six children: clinical and immunological studies. Allergy 1980;35:581-587. Australian Family Physician. Tetanus immunoprophylaxis. Australian Family Physician 1978;7:431-435. Avery OT, Goebel WF. Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-protein antigens. Journal of Experimental Medicine 1929;50:533-550. Ayoola EA, Johnson AO. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants. International Journal of Gynaecology and Obstetrics 1987;25:297-301.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Azeemuddin S. Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella (letter). Clinical Pediatrics 1987;26:318. Azimi PH, Cramblett HG, Haynes RE. Mumps meningoencephalitis in children. Journal of the American Medical Association 1969;207:509-512. Azzopardi P. Mumps meningitis, possibly vaccine-related—Ontario. Canada Diseases Weekly Report 1988;14:209-211. Babbott FL Jr., Gordon JE. Modem measles. American Journal of Medical Science 1954;228:334-361. Bach C, Allard M. [Acute thrombocytopenic purpura after measles vaccination. Report of a case]. Purpura thrombopenique aigu apres vaccination antirougeoleuse. A propos d'une observation. Semaine des Hopitaux de Paris 1974;50:589-593. Bachand AJ, Rubenstein J, Morrison AN. Thrombocytopenic purpura following live measles vaccine. American Journal of Diseases of Children 1967;113:283-285. Backes CR. Immunization practices and controversies 1981: Part 1. The "big seven" vaccines. Journal of the American Osteopathic Association 1981;80:595-603. Bader M. Perspectives on the relative resurgence of mumps in the United States. American Journal of Diseases of Children 1988;142:1021-1022. Bader M. Polio vaccination during pregnancy (letter). Journal of the American Medical Association 1983;249:2018-2019. Bader M. Risks from polio vaccination (letter). Journal of the American Medical Association 1984;251:728-729. Baer CL, Bratt DE, Edwards R, McFarlane H, Utermohlen V. Response of mildly to moderately malnourished children to measles vaccination. West Indian Medical Journal 1986;35:106-111. Baguley DM, Glasgow GL. Subacute sclerosing panencephalitis and Salk vaccine. Lancet 1973;2:763-765. Bajoghli M, Naficy AR, Vafai A, Shafa G. Paralytic poliomyelitis in Isfahan. Journal of Tropical Pediatrics and Environmental Child Health 1977;23:236-238. Bak P. Guillain-Barre syndrome in a Danish county. Neurology 1985;35:207-211. Bakanov MI. [Development of bronchial asthma attacks in children under the effect of prophylactic immunization] Vozniknovenie pristupov bronkhial'noi astmy u detei pod vliianiem profilakticheskoi immunizatsii. Voprosy Okhrany Materinstva i Detstva 1968;13:78-79. Balduzzi P, Glasgow LA. Paralytic poliomyelitis in a contact of a vaccinated child. New England Journal of Medicine 1967;276:796-797. Balfour HH Jr., Amren DP. Rubella, measles and mumps antibodies following vaccination of children: a potential rubella problem. American Journal of Diseases of Children 1978; 132:573-577. Banatvala JE. Insulin-dependent (juvenile-onset, type I) diabetes mellitus: Coxsackie B viruses revisited. Progress in Medical Virology 1987;34:33-54. Banker DD. Problems in preparation, testing and use of diphtheria, pertussis and tetanus vaccines. Progress in Drug Research 1975;19:229-240. Banton HJ, Miller PA. An observation of antitoxin titers after booster doses of tetanus toxoid. New England Journal of Medicine 1949;240:13-14. Bar-Joseph G, Etzioni A, Hemli J, Gershoni-Baruch R et al. Guillain-Barre syndrome in three siblings less than 2 years old. Archives of Disease in Childhood 1991;66:1078-1079. Baraft LJ, Cherry JD. Nature and rates of adverse reactions associated with pertussis immunization. In: Third International Symposium on Pertussis, National Institutes of Health, 1978. Publication No. (NIH) 79-1830. Bethesda, Md.: Department of Health, Education, and Welfare; 1979:291-296. Baraft LJ, Cherry JD. Reactogenicity of DTP and DT vaccine. Clinical Research 1979;27:112. Baraff L J, Cherry JD. Reactogenicity of DTP and DT vaccines. Pediatric Research 1979;13:794. Baraff LJ, Cherry JD, Cody CL, March SM, Manclark CR. DTP vaccine reactions: effect of

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality prior reactions on rate of subsequent reactions. Developments in Biological Standardization 1985;61:423-428. Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy SM. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatric Infectious Disease Journal 1989;8:502-507. Barbanti-Brodano G, Oyanagi S, Katz M, Koprowski H. Presence of two different viral agents in brain cells of patients with subacute sclerosing panencephalitis (SSPE). Proceedings of the Society for Experimental Biology and Medicine 1970;134:230-236. Barbor PR, Grant DB. Encephalitis after measles vaccination. Lancet 1969;2:55-56. Barbour ML. Haemophilus influenzae type b: carriage and immunity four years after conjugate vaccination. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 978, p. 273. Washington, DC: American Society for Microbiology; 1992. Barkin RM, Pichichero ME. Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics 1979;63:256-260. Barkin RM, Hendley JO, Zahradnik J et al. Capsular polysaccharide Haemophilus influenzae type b vaccine: clinical and immunologic responses to two vaccines . Pediatric Infectious Disease Journal 1987;6:20-23. Barkin RM, Pichichero ME, Samuelson JS, Barkin SZ. Pediatric diphtheria and tetanus toxoids vaccine: clinical and immunologic response when administered as the primary series. Journal of Pediatrics 1985;106:779-781. Barkin RM, Samuelson JS, Gotlin LP. DTP reactions and serologic response with a reduced dose schedule. Journal of Pediatrics 1984;105:189-194. Barkin RM, Samuelson JS, Gotlin LP. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule. Developments in Biological Standardization 1985;61:297-307. Barkin RM, Samuelson JS, Gotlin LP, Barkin SZ. Primary immunization with diphtheria-tetanus toxoids vaccine and diphtheria-tetanus toxoids-pertussis vaccine adsorbed: comparison of schedules. Pediatric Infectious Disease 1985;4:168-171. Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. The FASEB Journal 1992;6:840-844. Barra A, Cordonnier C, Preziosi MP, Intrator L, Hessel L, Fritzell B et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. Journal of Infectious Diseases 1992;166:1021-1028. Barrucand D, Schmitt J, Schmidt CL. [Neuropsychiatric complications of rabies immunization] Accidents neuro-psychiatriques de la vaccination antirabique. Annales Medicales de Nancy 1977;16:705-714. Barsky P. Measles: Winnipeg, 1973. Canadian Medical Association Journal 1974;110:931-934. Bart KJ, Orenstein WA, Hinman AR. The current status of immunization principles: recommendations for use and adverse reactions. Journal of Allergy and Clinical Immunology 1987;79:296-315. Bartelheimer HK, Mai K. [Tetanus vaccination in relation to the importance of protection by vaccination] Aktuelles zur Tetanusimpfung im Hinblick auf die Erkennung des Impfshcutzes. Monatsschrift fur Kinderheilkunde 1970;118:558-560. Basillico FC, Bernat JL. Vaccine-associated poliomyelitis in a contact. Journal of the American Medical Association 1978;239:2275. Basu RN. Measles vaccine: feasibility, efficacy and complication rates in a multicentric study. Indian Journal of Pediatrics 1984;51:139-143. Basu SN. Paralytic poliomyelitis following inoculation with combined diphtheria-tetanus-pertussis prophylactic: a review of sixteen cases with special reference to immunization schedules in infancy. Journal of the Indian Medical Association 1973 ;60:97-99.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Basu SN. A review of paralytic poliomyelitis cases occurring after polio vaccination. Journal of the Indian Medical Association 1986;84:203-206. Bateman DE, Elrington G, Kennedy P, Saunders M. Vaccine related poliomyelitis in nonimmunised relatives and household contacts. British Medical Journal 1987;294:170-171. Bather R, Furesz J, Fanok AG et al. Long-term infection of diploid African green monkey brain cells by Schwarz measles vaccine virus. Journal of General Virology 1973;20:401-405. Baublis JV, Payne FE. Measles antigen and syncytium formation in brain cell cultures from subacute sclerosing panencephalitis (SSPE). Proceedings of the Society for Experimental Biology and Medicine 1968;129:593-597. Baust W, Meyer D, Wachsmuth W. Peripheral neuropathy after administration of tetanus toxoid. Journal of Neurology 1979;222:131-133. Baxley LM. Tetanus is still deadly Occupational Health and Nursing 1981;29:40-42. Beale AJ. Hazards of vaccine production. FEMS Microbiology Letters 1992;79:469-473. Beale AJ. Measles vaccines. Proceedings of the Royal Society of Medicine 1974;67:1116-1119. Beard CM, Benson RC, Kelalis PP, Elveback LR, Kurland LT. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935-1974. Mayo Clinic Proceedings 1977;52: 3-7. Beasley RP, Hwang LY, Lee GC. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102. Beaussart M, Lacombe A, Fourrier A, Camier P. [Electroencephalographic study during measles vaccination using the Schwarz vaccine] Etude electroencephalographique au cours de la vaccination contre la rougeole par le vaccin Schwarz. Revue Neurologique 1969;121:324-325. Beck M, Welsz-Malecek R, Mesko-Prejac M, Radman V, Juzbasic M, Rajninger-Miholic Met al, Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. Journal of Biological Standardization 1989;17:85-90. Beck SA, Williams LW, Shirrell MA, Burks AW. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Pediatrics 1991;88:913-917. Beckmann R, Manz F, Moser R. [Increased occurrence of "sporadic" spinal progressive muscular atrophy in infancy] Gehauftes "sporadisches" Vorkommen spinaler progressiver Muskelatrophien im Kindesalter. Monatsschrift fur Kinderheilkunde 1970;118:41-44. Becus-Laurentiu M, Szabo-Adorjan E, Pozsgi N, Szabo S. Etude histochimique de l'ovaire de ratte: l'effet du choc anaphylactique et du vaccin pertussis. Archives Roumaines de Pathologie Experimentale et de Microbiologie 1974;33:97-106. Beede WE, Newcomb RW. Lower motor neuron paralysis in association with asthma. Johns Hopkins Medical Journal 1980;147:186-187. Beersma MF, Kapsenberg JG, Renier WO, Galama JM, van Druten JA, Lucas CJ. [Subacute sclerosing panencephalitis in The Netherlands (1976-1986)] Subacute scleroserende panencefalitis in Nederland (1976-1986). Nederlands Tijdschrift voor Geneeskunde 1988; 132:1194-1199. Begaud B, ed, Analyse d'Incidence en Pharmacovigilance: Application a la Notification Spontanee. Bordeaux: ARME-Pharmacovigilance Editions: 1991. Begg NT, Noah ND, Crowley S, Al-Jawad ST, Kovar IZ. Mumps, measles, and rubella vaccination and encephalitis (letter). British Medical Journal 1989;299:978. Beghi E, Cornelio F, Marconi M, Rizzuto N, Tonali P. The epidemiology of inflammatory polyradiculoneuropathy: a critical review of the distribution. characteristics and outcome of the disease. Plasmapheresis Study Group. Italian Journal of Neurologic Science 1991:12:63-73. Beghi E, Kurland LT, Mulder DW. Incidence of acute transverse myelitis in Rochester, Minne-

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality sota, 1970-1980, and implications with respect to influenza vaccine. Neuroepidemiology 1982;1:176-188. Beghi E, Kurland LT, Mulder DW, Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Annals of Neurology 1985;18:320-323. Beghi E, Kurland LT, Mulder DW, Wiederholt WC. Guillain-Barre syndrome: clinicoepidemiologic features and effect of influenza vaccine. Archives of Neurology 1985;42:1053-1057. Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA, Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981. I. Epidemiology. Annals of Neurology 1984;16:283-294. Behan PO. Diffuse myelitis associated with rubella vaccination. British Medical Journal 1977;1:166. Bell EJ, Riding MH, Grist NR. Paralytic poliomyelitis: a forgotten diagnosis? British Medical Journal 1986;293:193-194. Bell JF. Canine distemper, measles, and SSPE. American Journal of Epidemiology 1978;107:354-355. Bellanti JA, Sanga RL, Klutinis B et al. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. New England Journal of Medicine 1969;260:628-633. Bellini WJ, Rota JS, Greer FW, Zaki SR et al. Measles vaccination death in a child with severe combined immunodeficiency: report of a case. Laboratory Investigation 1992;66:19A. Bellman MH, Rawson NS, Wadsworth J, Ross EM, Cameron S, Miller DL. A developmental test based on the STYCAR sequences used in the National Childhood Encephalopathy Study. Child: Care, Health and Development 1985;11:309-323. Bellman MH, Ross EM, Miller DL. Infantile spasms and pertussis immunization. Lancet 1983;1:1031-1034. Benacerraf B, Kabat EA. A quantitative study of the Artbus phenomenon induced passively in the guinea pig. Journal of Immunology 1950;64:1-19. Bendersky-Malbec N. [Mumps in 1982: current situation concerning anti-mumps vaccine] Les oreillons en 1982: raise au point sur le vaccin anti-ourlien. Concours Medecin 1982;104:167-177. Bengtsson B. [The side effects of the vaccination of 650 children against measles] Biverkningar vid masslingsvaccination av 650 barn. Lakartidningen 1971;68:2235-2244. Benison S. International medical cooperation: Dr. Albert Sabin, live poliovirus vaccine and the Soviets. Bulletin of the History of Medicine 1982;56:460-483. Benjamin CM, Chew GC, Silman AJ. Joint and limb symptoms in children after immunization with measles, mumps, and rubella vaccine. British Medical Journal 1992;204:1075-1078. Benjamin CM, Silman AJ. Adverse reactions and mumps, measles and rubella vaccine. Journal of Public Health Medicine 1991;13:32-34. Bennett AD, Modlin J, Orenstein WA, Brandling. Current status of mumps in the United States. Journal of Infectious Diseases 1975;132:106-109. Bensasson M, Lanoe R, Assan R. [A case of algodystrophy of the upper limb occurring after tetanus vaccination] Un cas de syndrome algodystrophique du membre superieur survenu apres vaccination antitetanique. Semaine des Hopitaux de Paris 1977;53:2965-2966. Bergeisen GH, Bauman RJ, Gilmore RL. Neonatal paralytic poliomyelitis: a case report. Archives of Neurology 1986;43:192-194. Berger JR, Ayyar DR, Sheremata WA. Guillain-Barre syndrome complicating acute hepatitis B: A case with detailed electrophysiological and immunological studies. Archives of Neurology 1981;38:366-368. Bergeson PS. Immunizations to the deltoid region (letter). Pediatrics 1990;85:134-135. Bergey GK, Bigalke H, Nelson PG. Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. Journal of Neurophysiology 1987;57:121-131.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Bergmannova V, Stehlikova J, Domorazkova E. [Immunization of children with reactions to the mixed vaccine against diphtheria, tetanus and whooping cough]. Ceskoslovenska Pediatrie 1988;43:522-526. Bergouignan FX, Saintarailles J, Roux D, Guillon J, Bonnici JF, Fleury H et al. [Prevention of poliomyelitis: live or killed vaccine? Remarks apropos of 2 cases of poliomyelitis] Prevention de la poliomyelite: vaccin vivant ou rue? Reflexions a propos de 2 cas de poliomyelite. Presse Medicale 1984;13:2241-2243. Berkovich S, Fikrig S, Brunell PA, Steiner M. Effect of live attenuated mumps vaccine virus on the expression of tuberculin sensitivity. Journal of Pediatrics 1972;80:84-87. Berkowitz CD, Ward JI, Chiu CE, Marcy SM, Gordon L, Hendley JO et al. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age. Pediatrics 1990;85:288-293. Berkowitz CD, Ward JI, Meier K et al. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age. Journal of Pediatrics 1987;110:509-514. Berlin BS. Convulsions after measles immunization (letter). Lancet 1983;1:1380. Bernal A. Garcia-Saiz A, Liacer A, De Ory F, Tello O, Najera R. Poliomyelitis in Spain, 1982-1984: virologic and epidemiologic studies. American Journal of Epidemiology 1987;126: 69-76. Bernard KW, Smith PW, Kader FJ, Moran MJ. Neuroparalytic illness and human diploid cell rabies vaccine. Journal of the American Medical Association 1982;248:3136-3138. Bernier RH. Improved inactivated poliovirus vaccine: an update. Pediatric Infectious Disease 1986;5:289-292. Bernstein DI, Smith VE, Schiff GM, Rathfon HM, Boscia JA. Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. Pediatric Infectious Disease Journal 1993;12:131-135. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Research 1992;52(Suppl.):5510s-5515s. Bernuau J. [Hepatitis B virus vaccination: a neglected, understated risk] Vaccination contre le virus B de l'hepatite: "un risque ignore, sous-evalue, neglige". Concours Medical 1990;112:1062. Berry S, Hernandez H, Kanashiro R, Campos M, Azabache V, Gomez G et al. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants. Pediatric Infectious Disease Journal 1992;11:822-827. Bhagwat SM, Samuel MR. Oral polio vaccine (Sabin): vaccine-associated poliolike illnesses. Indian Journal of Medical Science 1966;29:903-906. Bhaskaram P, Madhusudan J, Radhakrishna KV, Raj S. Immunological response to measles vaccination in poor communities. Human Nutrition and Clinical Nutrition 1986:40:295-299. Bhatnagar SK, Mohan M, Kumar P, Balaya S, Prabhakar AK, Bhargava SK. Optimum age for measles immunization: study of pre- and postimmunization level of HI antibody titres. Indian Pediatrics 1981;18:625-629. Bianchi R, Dappen U, Hoigne R. [Anaphylactic shock of humans towards foreign species serum: symptomatology, prevention and therapy] Der anaphylaktische Schock des Menschen auf artfremdes Serum: Symptomatologie, Prophylaxe und Therapie. Helvetica Chirurgica Acta 1967;34:257-273. Biarez O, Sarrut B, Doreau CG, Etienne J. Comparison and evaluation of nine bibliographic databases concerning adverse drug reactions. DICP, The Annals of Pharmacotherapy 1991;25:1062-1065. Biberi-Moroeanu S, Muntiu A. Commentary on the oral poliomyelitis vaccine (Sabin): associ-

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Sutton GC. Mumps, measles and rubella vaccination: a pragmatic study. Public Health 1991;105:133-138. Swaak AJ. [Local reactions following booster injections with DWTP-vaccine (diphtheria-whooping cough-tetanus-poliovirus vaccine) in children born in 1960 and 1961] Lokale klachten bijkinderen van de jaarklassen 1960 en 1961 na een herbalingsinjectie met DKTP-entstof. Nederlands Tijdschrift voor Geneeskunde 1966;110:332-334. Swaak AJ. [A study of children born in 1962 on the relation between local complaints and the type of vaccine used in the immunization for whooping cough, diphtheria, tetanus and poliomyelitis] Een onderzoek bij kinderen van de jaarklasse 1962 naar het verband tussen de lokale klachten en de aard van de entstof bij de immunisatie tegen kinkhoest, difterie, tetanus en poliomyelitis. Nederlands Tijdschrift voor Geneeskunde 1966;110:1696-1699. Swanson PD, McAlister R, Peterson DR. Poliomyelitis associated with type 2 virus: paralytic disease in the father of a recently immunized child. Journal of the American Medical Association 1967;201:771-773. Swartz TA, Klingberg W, Klingberg MA. Combined trivalent and bivalent measles, mumps and rubella virus vaccination: a controlled trial. Infection 1974;2:115-117. Syrogiannopoulos GA, Hansen EJ, Erwin AL et al. Haemophilus influenzae type b lipooligosaccharide induced meningeal inflammation. Journal of Infectious Diseases 1988;157:237-244. Szillat K, Meyke M, Kopsel G. [Sequelae following triple vaccination (epidemic parotitis, measles, rubella)?] Enzephalitis, Meningitis serosa und Parotitis nach MMR-Schutzimpfung? Kinderarztliche Praxis 1992;60:203. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 1980;303:833-841. Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE et al. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. New England Journal of Medicine 1982;307:1481-1486. Tabor E. Guillain-Barre syndrome and other neurologic syndromes in hepatitis A, B, and Non-A, Non-B. Journal of Medical Virology 1987;21:207-216. Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991 ;164:982-986. Takasu T, Kondo K, Ahmed A, Yoshikawa Y, Yamanouchi K, Tsuchiya M et al. Elevated ratio of late measles among subacute sclerosing panencephalitis patients in Karachi, Pakistan. Neuroepidemiology 1992;11:282-287. Takayama N, Kidokoro M, Suzuki K, Morita M. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine]. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 1992;66:776-780. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A, Sugiura A. Variations of nucleotide sequences and transcription of the SH gene arnong mumps virus strains. Virology 1991;181:364-366. Tan KL, Oon CJ, Goh KT, Wong LY, Chan SH. Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine. Acta Paediatrica Scandinavica 1990;79:593-598. Tanabayashi K, Takeuchi K, Hishiyama M, Yamada A, Tsurudome M, Ito Y et al. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein . Virology 1990;177:124-130. Taranger J. Wiholm BE. [The low number of reported adverse effects after vaccination against measles, mumps, rubella] Litet antal biverkningar rapporterade efter vaccination mot massling-passjuka-roda hund. Lakartidningen 1987;84:948-950.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Tarlov IM. Paralysis caused by penicillin injection; mechanism complication—a warning. Journal of Neuropathology and Experimental Neurology 1951;10:158-176. Taylor EM, Emery JL. Immunization and cot deaths (letter). Lancet 1982;2:721. Telzak E, Wolff SM, Dinarello CA et al. Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine. Journal of Infectious Diseases 1986;153:628-633. Terpstra GK, Raaijmakers JA, Kreukniet J. Comparison of vaccination of mice and rats with Haemophilus influenzae and Bordetella pertussis as models of atopy. Clinical and Experimental Pharmacology and Physiology 1979;6:139-149. Terpstra GK, Raaijmakers JA, Hamelink M, Kreukniet J. Effects of Haemophilus influenzae vaccination on the (para-)sympathic-cyclic nucleotide-histamine axis in rats. Annals of Allergy 1979;42:36-40. Thacker SB. Meta-analysis: a quantitative approach to research integration. Journal of the American Medical Association 1988;259:1685-1689. Themann J. Hepatitis B aktuell: erst lust—dann frust. Therapiewoche 1991;41:2154. Thesen R. [Haemophilus influenzae type b vaccines] Hib-vakzine. Pharmazeutische Zeitung 1990;135:30, 32, 34, 36. Thier SO. Importance of the single case. New England Journal of Medicine 1968;278:1347. Thomas GA, O'Brien RT. Thrombocytosis in children with Haemophilus influenzae meningitis. Clinical Pediatrics 1986;25:610-611. Thomas P. Immunization of children infected with HIV: a public health perspective. Pediatric Annals 1988;17:347-351. Thomison JB. The price of safety (editorial). Southern Medical Journal 1990;83:494-496. Thompson WL. Adverse drug reactions: finding sharp safety signals in a noisy haystack. Food Drug Cosmetic Law Journal 1991;46:487-502. Thormar H, Mehta PD, Barshatzky MR, Brown HR. Measles virus encephalitis in ferrets as a model for subacute sclerosing panencephalitis . Laboratory Animal Science 1985;35:229-232. Thraenhart O, Kuwert E. [Intratypic differentiation of poliovirus strains with special regard to complication after oral vaccination in West-Germany]. Intratypische charakterisierung von poliovirussammen unter besonderer Berucksichtigung der impfreaktion nach schluckimpfung. Sentralblatt fur Bakteriologic, Parasitunkunde, Infektionskrankheiten und Hygiene 1972;221:143-156. Thurston A. Anaphylactic shock reaction to measles vaccine (letter). Journal of the Royal College of General Practice 1987;37:41. Tidjani PO, Grunitzky B, Guerin N, Levy-Bruhl D, Lecam N, Xuereff C et al. [Comparative serological efficacy of anti-measles vaccine strains Edmonston-Zagreb, Schwarz and AIKC in Togolese infants of 4-5 months and 8-10 months]. Efficacité sérologique comparative des souches de vaccin antirougeoleux Edmonston-Zagreb, Schwarz et AIK-C chez des enfants togolois de 4-5 moise et 8-10 mois. Bulletin de la Societe de Pathologie Exotique 1991;84(5 Pt 5):873-884. Tishon A, Oldstone MB. Persistent virus infection associated with chemical manifestations of diabetes. American Journal of pathology 1987;126:61-72. Todd JK, Bruhn FW. Severe Haemophilus influenzae infections: spectrum of disease. American Journal of Diseases in Children 1975;129:607-611. Toffler WL, Olenick JS, Wolf NE, Retzlaff ZH, Swanson JR, Kenny TA. The immunogenicity and safety of intradermal hepatitis B vaccine. Journal of Family Practice 1991;33:149-154. Topaloglu H, Berker M, Kansu T, Saatci U, Renda Y. Optic neuritis and myelitis after booster tetanus toxoid vaccination (letter). Lancet 1992;339:178-179. Topley WW. The role of active or passive immunization in the control of enteric infection. Lancet 1938;1:181-186.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Toraldo R, Tolone C, Catalanotti P, Ianniello R, D'Avanzo M, Canino G et al. Effect of measles-mumps-rubella vaccination on polymorphonuclear neutrophil functions in children. Acta Paediatrica 1992;81:887-890. Toreki W. Risk management: National Childhood Vaccine Injury Act of 1986. Trends in Health Care, Law and Ethics 1992;7:41-44. Torinuki W. Mucha-Habermann disease in a child: possible association with measles vaccination. Journal of Dermatology 1992;19:253-255. Tosti A, Melino M, Bardazzi F. Systemic reactions due to thiomersal. Contact Dermatitis 1986;15:187-188. Trinca JC. Active immunization against tetanus: the need for a single all-purpose toxoid. Medical Journal of Australia 1965;2:116-120. Trinca JC. Combined diphtheria-tetanus immunization of adults. Medical Journal of Australia 1975;2:543-546. Trinca JC. Over-immunization: an ever present problem. Australian Family Physician 1976;5:734-755. Trollfors B, Lagergard T, Claesson BA, Thornberg E, Martinell J, Schneerson R. Characterization of the serum antibody response to the capsular polysaccharide Haemophilus influenzae type b in children with invasive infections. Journal of Infectious Diseases 1992;166:1335-1339. Trump RC, White TR. Cerebellar ataxia presumed due to live, attenuated measles virus vaccine. Journal of the American Medical Association 1967;199:129-130. Tsairis P, Dyck PJ, Mulder DW. Natural history of brachial plexus neuropathy: report on 99 patients. Archives of Neurology 1972;27:109-117. Tsukada N, Koh C-S, Owa M, Yanagisawa N. Chronic neuropathy associated with immune complexes of hepatitis B virus. Journal of the Neurological Sciences 1983;61:193-211. Tsukada N, Koh C-S, Inoue A, Yanagisawa N. Demyelinating neuropathy associated with hepatitis B infection: detection of immune complexes composed of hepatitis B virus surface antigen. Journal of the Neurological Sciences 1987;77:203-216. Tubert P, Begaud B, Pere JC, Haramburu F, Lellouch J. Power and weakness of spontaneous reporting: a probabilistic approach. Journal of Clinical Epidemiology 1992;45:283-286. Tudela P, Marti S, Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B (letter). Nephron 1992;62:236. Tudor-Williams G, Frankland J, Isaacs D, Mayon-White RT, MacFarlane JA, Rees DG et al. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Archives of Disease in Childhood 1989;64:520-524. Tuft L et al. Allergic reactions following immunization procedures. Archives of Environmental Health 1966;13:91-95. Tuohy PG. Guillain-Barre syndrome following immunization with synthetic hepatitis B vaccine (letter). New Zealand Medical Journal 1989;102:114-115. Turner PC, Forsey T, Minor PD. Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccinees. Journal of General Virology 1991;72(Pt 2):435-437. Tyufanov AV, Stefanov SB. [Seasonal differences in the pathomorphological reactions of monkeys to poliomyelitis vaccine] Sezonnye razlichiia patomorfologicheskikh reaktsii obez'ian na vaktsinu protiv poliomielita. Voprosy Virusologii 1983;2:238-240. U.S. Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General. PHS Publ. No. 1003. Washington, DC: U.S. Public Health Service, U.S. Department of Health, Education, and Welfare; 1964. U.S. Department of Health and Human Services, U.S. Public Health Service. National Vaccine Injury Compensation Program; Revision of the Vaccine Injury Table; Proposed Rule. Federal Register, 42 CFR Part 100, August 14. 1992;57(158):36877-36885.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality U.S. Public Health Service. Interim document gives advice on use of Salk and Sabin vaccines. Journal of the American Medical Association 1962; 180:23-26. Uchida T. Diphtheria toxin. In: Dorner F, Drews J, eds. Pharmacology of Bacterial Toxins IEPT Section 199. Oxford: Pergamon Press; 1986. Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barre cases after an oral poliovaccine campaign (letter). Lancet 1989:2:440-441. Ullberg-Olsson K. [Vaccination reactions after injection of tetanus toxoid with and without diphtheria toxoid] Vaccinationsreaktioner efter injektion av tetanus toxoid med och utan tillsats av difteritoxoid. Lakartidningen 1979;76:2976. Vaandrager GJ, Molenaar JL, Bruining GJ, Plantinga AD, Ruitenberg EJ. Islet cell antibodies, mumps infection and mumps vaccination (letter). Diabetologia 1986;29:406-407. Vadheim CM. Reduction of Hib disease in Southern California, 1983-1991. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 1726, p. 398. Washington, DC: American Society for Microbiology; 1992. Vadheim CM, Greenberg DP, Marcy SM, Froeschle J, Ward JI. Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children. Pediatric Infectious Disease Journal 1990;9:555-561. Vallancourt RJ. Current poliovirus vaccines. Reviews of Infectious Diseases 1984;6(Suppl. 2):S328-S330. Valman HB. Convulsions in the older infant. British Medical Journal 1989:299:1331-1333. Valmari P, Lanning M, Tuokko H, Kouvalainen K. Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy. Pediatric Infectious Disease Journal 1987;6:59-63. van Alphen L, Bijlmer HA. Molecular epidemiology of Haemophilus influenzae type b. Pediatrics 1990;85(4 Pt 2):636-642. Van Asperen PP, McEniery J, Kemp AS. Immediate reactions following live attenuated measles vaccine. Medical Journal of Australia 1981;2:330-331. van Bogaert L. Une leucoencephalite sclerosante subaigue. Journal de Neurologie et de Psychiatrie 1945;8:101-120. Van de Voorde A. Eye of the needle. Westword 1992;15:10-12, 15-16. van der Meché FG, Schmitz PI, Dutch Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. New England Journal of Medicine 1992;326:1123-1129. van Heyningen S. Tetanus toxin. In: Dorner F, Drews J, eds. Pharmacology of Bacterial Toxins IEPT Section 199. Oxford: Pergamon Press; 1986. van Ramshorst JD, Cohen H, Levine L, Edsall G. The relation between animal potency tests and the human response to adsorbed tetanus toxoids. Journal of Biological Standardization 1973;1:215-220. Varughese PV, Carter AO, Acres SE, Furesz J. Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies. Canadian Journal of Public Health 1989;80:363-368. Vassilev TL. Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy 1978;33:155-159. Vella PP, Staub JM, Armstrong J, Dolan KT, Rusk CM, Szymanski S et al. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB). Pediatrics 1990;85(4 Pt 2):668-675. Vellayappan K, Lee CY. Tetanus toxoid hypersensitivity. Journal of the Singapore Paediatric Society 1976;18:17-19. Venulet J. Assessing Causes of Adverse Drug Reactions with Special Reference to Standardized Methods. London: Academic Press: 1982.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Verduzco Guerrero E, Calderon C, Velazquez Franco E. [Repercussions of vaccination against measles] Repercusiones de la vacunacion contra el sarampion. Salud Publica de Mexico 1974;16:707-720. Vesikari T, Ala-Laurila EL, Heikkinen A, Kuusinen H, Terho A. [Efficacy and side effects of live attenuated single mumps and measles vaccines, and bivalent mumps-measles vaccine in young infants] Elava sikotautirokote yksin ja tuhkarokko-rokotteeseen yhdistettyna pienilla lapsilla. Duodecim 1982;98:839-847. Vesikari T, Ala-Laurila EL, Heikkinen A, Terho A, D'Hondt E, Andre FE. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. American Journal of Diseases of Children 1984;138:843-847. Vesikari T, Andre FE, Simoen E, Florent G, Ala-Laurila EL, Heikkinen A et al. Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain. Acta Paediatrica Scandinavica 1983;72:37-40. Vesikari T, Andre FE, Simoen E, Florent G, Ala-Laurila EL, Heikkinen A et al. Comparison of the Urabe Am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children. Acta Paediatrica Scandinavica 1983;72:41-46. Vessal S, Kravis LP. Immunologic mechanisms responsible for adverse reactions to routine immunizations in children . Clinical Pediatrics 1976;15:688-696. Vijay HM, Huang H, Young NM, Bernstein IL et al. Studies on alternaria allergens. I. Isolation of allergens from alternaria tenuis and alternaria solani. International Archives of Allergy and Applied Immunology 1979;60:229-239. Vijay HM, Lavergne G, Huang H, Bernstein IL et al. Preferential synthesis of IgE reaginic antibodies in rats immunized with alum-adsorbed antigens. International Archives of Allergy and Applied Immunology 1979;59:227-232. Villaca LM, de Macedo DD. [Subacute sclerosing panencephalitis with partial remission] Panencefalite esclerosante subaguda com remissao parcial. Arquivos de Neuropsiquiatria 1979;37:435-442. Vivell O. [Oral vaccination against poliomyelitis] Poliomyelitis-Schluckimpfung. Deutsche Medizinische Wochenschrift 1973;98:1049. Vogel C. [Complication by contact after vaccination against poliomyelitis]. Zum Thema Impfkomplikation (am beispiel einer impf-kontakt-poliomyelitis). Kinderarztliche Praxis 1980:48:296-299. Volk VK. Safety and effectiveness of multiple antigen preparations in a group of free-living children. American Journal of Public Health 1949;39:1299-1313. Volk VK, Gottshall RY, Anderson HD et al. Antibody response to booster dose of diphtheria and tetanus toxoids: reactions in institutionalized adults and noninstitutionalized children and young adults . Public Health Reports 1963;78:161-164. Volk VK, Gottshall RY, Anderson HD, Top FH, Bunney WE, Serfling RE. Antigenic response to booster dose of diphtheria and tetanus toxoids: seven to thirteen years after primary inoculation of noninstitutionalized children. Public Health Reports 1962;77:185-194. von Muhlendahl KE. [Side effects and complications of measles-mumps vaccination] Nebenwirkungen und Komplikationen der Masern-Mumps-Impfung. Monatsschrift fur Kinderheilkunde 1989;137:440-446. von Muhlendahl KE. Side-effects of measles-mumps vaccination (letter). Lancet 1990;335:540-541. von Muhlendahl KE, Eguiluz GC, Trallero EP, Thalayasingam B. Mumps meningitis following measles, mumps, and rubella immunization. Lancet 1989;2:394-395. von Reyn CF, Clements CJ. Mann JM. Human immunodeficiency virus infection and routine childhood immunization. Lancet 1987;2:669-672. Von Seefried A, Chun JH, Grant JA, Letvenuk L, Pearson EW. Inactivated poliovirus vaccine and test development at Connaught Laboratories LTD. Reviews of Infectious Diseases 1984;6(Suppl. 2):S345-S349.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality von Wirth G. Reversible kochlearisschadigung nach Tetanol-Injektion? Munchener Medizinische Wochenschrift 1965;107:379-381. Voss L, Lennon D, Gillies M. Haemophilus influenzae type b disease in Auckland children 1981-87. New Zealand Medical Journal 1989;102:149-151. Wahl M, Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scandinavian Journal of Infectious Diseases 1987;19:617-621. Waight PA, Pollock TM, Miller E, Coleman EM. Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Archives of Disease in Childhood 1983;58:921-923. Waisbren BA. A commentary regarding personal observations of demyelinizing disease caused by viral vaccines, borrelia infections, and proteolytic enzymes. Submitted to the Institute of Medicine Committee on Vaccine Safety, August 11, 1992. Wakeel RA, White MI. Erythema multiforme associated with hepatitis B vaccine (letter). British Journal of Dermatology 1992;126:94-95. Waksman BH, Adams RD. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. Journal of Experimental Medicine 1955;102:213-235. Walker AM, Jick H, Perera DR, Thompson RJ, Knauss TA. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. American Journal of Public Health 1987;77:945-951. Walker AM, Martin-Moreno JM, Artalejo FR. Odd man out: a graphical approach to metaanalysis. American Journal of Public Health 1988;78:961-966. Walter EB, Moggio MV, Drucker RP, Wilfert CM. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. Pediatric Infectious Disease Journal 1990;9:632-635. Walter Z, Walter T. [Six cases of poliomyelitis associated with oral immunization] Szesc przypadkow zachorowan na polio w powiazaniu ze szczepieniami doustnymi przeciw polio. Wiadomosci Lekarskie 1973;26:901-905. Wands JR, Mann E, Alpert E. The pathogenesis of arthritis associated with acute hepatitis B surface antigen-positive hepatitis: complement activation and characterization of circulating immune complexes. Journal of Clinical Investigation 1975;55:930-939. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE. Cytokine production in vitro and the lymphoproliferative defect of natural measles infection. Clinical Immunology and Immunopathology 1991;61:236-248. Ward JI. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine. Pediatrics 1990;85(4 Pt 2):667. Ward JI, Broome CV, Harrison LH, Shinefield H, Black S. Haemophilus influenzae type b vaccines: lessons for the future. Pediatrics 1988;81:886-893. Ward JI, Cochi S. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders; 1988. Wassilak SG. Adverse events following IPV. Prepared for Meeting of Immunization Practices Advisory Committee. October 24-25, 1985. Wassilak SG, Brink EW. Diseases controlled primarily by vaccination: tetanus. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992. Wassilak SG, Orenstein WA, Tetanus. In: Plotkin SA, Mortimer EA. eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988. Wassilak SG, Brink EW, Orenstein WA et al. Neurologic complications of oral poliomyelitis vaccine. Journal of Pediatrics 1987;110:996-998. Watemberg N, Dagan R, Arbelli Y, Belmaker I, Morag A, Hessel L et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatric Infectious Disease Journal 1991;10:758-763. Watson GI. The roseolar reaction (letter). British Medical Journal 1974;4:719-720. Watson JG. A child of 3 years who developed an encephalitic reaction to MMR (mumps, measles, rubella) immunization at age 15 months (letter). International Journal of Pediatric Otorhinolaryngology 1990;19:189-190. Weber G, Falk U. Vaccinations in the presence of skin diseases. International Journal of Dermatology 1975;14:136-140. Weckx LY, Schmidt BJ, Herrmann AA, Miyasaki CH, Novo NF. Early immunization of neonates with trivalent oral poliovirus vaccine. Bulletin of the World Health Organization 1992;70:85-91. Weekly Epidemiological Record. Expanded Programme on Immunization: reactions to tetanus toxoids. Weekly Epidemiological Record 1982;57:193-194. Weekly Epidemiological Record. Poliomyelitis: evaluation of poliovirus-related cases. Weekly Epidemiological Record 1990;65:159-162. Weekly Epidemiological Record. Expanded Programme on Immunization: serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population. Weekly Epidemiological Record 1992;6:179-182. Weekly Epidemiological Record. Expanded Programme on Immunization (EPI): safety of high titre measles vaccines. Weekly Epidemiological Record 1992;67:357-361. Wehrle PF. Injury associated with the use of vaccines. Clinical Therapeutics 1985:7:282-284. Weibel RE. Mumps vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988. Weibel RE, Stokes J, Buynak EB, Whitman JE, Hilleman MR. Live, attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. New England Journal of Medicine 1967;276:245-251. Weibel RE, Villarejos VM, Hernandez G, Stokes JJ, Buynak EB, Hilleman MR. Combined live measles-mumps virus vaccine. Archives of Disease in Childhood 1973;48:532-536. Weidmeier SE, Chung HT, Cho BH, Kim UH, Daynes RA. Murine responses to immunization with pertussis toxin and bovine albumin. I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction. Pediatric Research 1987;22:262-267. Weinberg GA, Granoff DM. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. Journal of Pediatrics 1988;113:621-631. Weinberg GA, Granoff DM. Immunogenicity of Haemophilus influenzae type polysaccharideprotein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine. Pediatrics 1990;85(4 Pt 2):654-661. Weinberg GA, Einhorn MS, Lenoir AA, Granoff PD, Granoff DM et al. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Journal of Pediatrics 1987;111:22-27. Weisman SJ, Cates KL, Allegretta GJ, Quinn JJ, Altman AJ. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer. Journal of Pediatrics 1987;111:727-729. Weiss R. Change the U.S. polio vaccine or leave it alone? ASM News (American Society for Microbiology) 1988;54:560-562. Weisse AB. Polio: the not-so-twentieth-century disease. Hospital Practice 1992;27:97-100, 104, 113-115, 119-120. Wells EC. Neurological note on vaccination against influenza. British Medical Journal 1971:3:755-756. Wenger JD, Fraser DW, Broome CV. Diseases controlled primarily by vaccination: Haemophilus

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality influenzae infections. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992. Wentz KR, Marcuse EK. Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence. Pediatrics 1991;87:287-297. Werne J, Garrow I. Fatal anaphylactic shock occurrence in identical twins following second injection of diphtheria toxoid and pertussis antigen. Journal of the American Medical Association 1946;131:730-735. Werner CA. Mumps orchitis and testicular atrophy: I. Occurrence. Annals of Internal Medicine 1950;32:1066-1074. Werner CA. Mumps orchitis and testicular atrophy. II. A factor in male sterility. Annals of Internal Medicine 1950;32:1075-1086. West DH, Calandra GB, Ellis RW. Vaccination of infants and children against hepatitis B. Pediatric Clinics of North America 1990;37:585-601. Westall FC, Root-Bernstein R. Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity. Lancet 1986;2:251-252. Wharton M, Cochi SL, Hutcheson RH, Bistowish JM, Schaffner W. A large outbreak of mumps in a postvaccine era. Journal of Infectious Diseases 1988;158:1253-1260. White CC, Koplan JP, Orenstein WA. Benefits, risks and costs of immunization for measles, mumps and rubella. American Journal of Public Health 1985;75:739-744. White F. Measles vaccine associated encephalitis in Canada (letter). Lancet 1983;2:683-684. White WG. Reactions after plain and adsorbed tetanus vaccines (letter). Lancet 1980;1:42. White WG, Barnes GM, Barker E, Gall D, Knight P, Griffith AH et al. Reactions to tetanus toxoid. Journal of Hygiene 1973;71:283-297. Whittingham HE. Anaphylaxis following administration of tetanus toxoid. British Medical Journal 1940;1:292-293. Whittle E, Roberton NR. Transverse myelitis after diphtheria, tetanus, and polio immunization. British Medical Journal 1977;1:1450. Whittle H, Hanlon P, O'Neill K, Hanlon L, Marsh V, Jupp E et al. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet 1988;2:811-814. WHO Consultative Group. The relation between acute persisting spinal paralysis and poliomyelitis vaccine: results of a ten-year enquiry. Bulletin of the World Health Organization 1982;60:231-242. Wiechers DO. New concepts of the reinnervated motor unit revealed by vaccine-associated poliomyelitis. Muscle and Nerve 1988;11:356-364. Wiechers DO. Reinnervation after acute poliomyelitis. Birth Defects 1987;23:213-221. Wiersbitzky S, Bruns R. [Bacterial meningitis following Hib-vaccination: a causal connection?] Meningitis purulenta nach Hib-Schutzimpfung: Kausaler zusammenhang? Kinderarztliche Praxis 1992;60:27. Wiersbitzky S, Bruns R. [Hib vaccinations and complications?] Schwere Gastroenteritis nach Hib-Schutzimpfung? Kinderarztliche Praxis 1992;60:102. Wiersbitzky S, Bruns R. Safety of vaccines in childhood. Lancet 1993;341:379. Wiersbitzky S, Bruns R, Beyer B. [Incubation vaccination (''postexposure vaccination'') with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit] Inkubationsimpfung ("Riegelungsimpfung") mit MMR-Vakzine wahrend einer Mumpsepidemie? Die padiatrische Impfberatungsstelle. Kinderarztliche Praxis 1992;60:207-208. Wiersbitzky S, Bruns R, Griefahn B, Wiersbitzky H. [Near-miss sudden infant death (nearly sudden infant death syndrome/NSIDS) following second DPT vaccination?] Beinahe plotzlicher Kindstod (Nearly Sudden Infant Death Syndrome/NSIDS) nach der 2. DPT-Impfung? Kinderarztliche Praxis 1992;60:246-248. Wiersbitzky S, Bruns R, Peters A, Mentel R. [Encephalitis, meningitis serosa and parotitis

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit] Enzephalitis, Meningitis serosa und Parotitis nach MMR-Schutzimpfung? Die padiatrische Impfberatungsstelle. Kinderarztliche Praxis 1992;60:203-205. Wiersbitzky S, Bruns R, Schroder C, Warmuth M. [Thrombocytopenic purpura following immunization with a live vaccine (mumps-measles-rubella vaccination)?] Thrombozytopenische Purpura nach Impfung mit Lebendvakzine (Mumps-Masern-Roteln-Schutzimpfung)? Kinderarztliche Praxis 1992;60:28-29. Wiersbitzky S, Bruns R, Wiersbitzky H. [Hyperpyretic reaction following combined vaccination DPT, Hib and oral polio in an infant] Hyperpyretische Reaktion nach kombinierter Hib-, DPT- und oraler Polio-Schutzimpfung bei einem Saugling? Kinderarztliche Praxis 1992;60:304-305. Wiesmann E, Keller HP, Steiner P. [Diphtheria vaccination of adults] Die Diphtherieimpfung Erwachsener. Schweizerische Medizinische Wochenschrift 1972;102:41-43. Wiggins CA, Dykewicz MS, Patterson R. Idiopathic anaphylaxis: a review. Annals of Allergy 1989;62:1-4. Wilfert CM. Epidemiology of Haemophilus influenzae type b infections. Pediatrics 1990;85(4 Pt 2):631-635. Wilhelm DJ, Paegle RD. Thrombocytopenic purpura and pneumonia following measles vaccination. American Journal of Diseases of Children 1967;113:534-537. Wilkinson JR. Measles immunization: contraindications perceived by general practitioners in one health district. Public Health 1986;100:144-148. Williamson S. Anti-vaccination leagues. Archives of Disease in Childhood 1984 ;59:1195-1196. Willinger M, James LS, Catz C et al. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatric Pathology 1991;11:677-684. Wilson GS. The Hazards of Immunization. London and New York: Oxford University Press (Athlone); 1967. Wilson J, Robinson R. Poliomyelitis after contact with recently vaccinated infant (letter). British Medical Journal 1974;2:53. Wilson LM. Some aspects of epidemiology in paediatric oncology. Proceedings of the Royal Society of Medicine 1975;68:657-659. Wilson S, Aprile MA. Sensitizing versus immunizing properties of inactivated measles vaccine. Progress in Immunobiological Standardization 1970;4:657-660. Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro J, Watkins RP. A prospective study of acute idiopathic neuropathy. II. Antecedent events. Journal of Neurology, Neurosurgery and Psychiatry 1988;51:613-618. Winner SJ, Evans G. Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. Quarterly Journal of Medicine 1990;77(New Series):1297-1304. Wolters KL, Dehmel H. Abschliessende untersuchungen uber die Tetanus Prophylaxe durch active Immunisierung. Zeitschrift fur Hygeitschrift 1942;124:326-332. Wong S, Dykewicz MS, Patterson R. Idiopathic anaphylaxis: a clinical summary of 175 patients. Archives of Internal Medicine 1974;150:1323-1328. Wong VC, Ip HM, Reesink HW. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin: double-blind randomised placebo-controlled study. Lancet 1984;1:921-926. Wong WK, Tan C, Ng SK, Goh CL. Thimerosal allergy and its relevance in Singapore. Contact Dermatitis 1992;26:195-196. Woods DR, Mason DD. Six areas lead national early immunization drive. Public Health Reports 1992;107:252-256.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Woolling KR, Ruston JG. Serum neuritis: report of two cases and brief review of the syndrome. Archives of Neurology and Psychiatry 1950;64:568-573. World Health Organization. Measles Vaccines, Technical Report No. 263. World Health Organization: Geneva; 1963. WRC-TV. DPT: Vaccine Roulette. Washington DC: WRC-TV, 1982. Wright PF, Hatch MH, Kasselberg AG, Lowry SP, Wadlington WB, Karzon DT. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. Journal of Pediatrics 1977;91:408-412. Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA et al. Strategies for the global eradication of poliomyelitis by the year 2000. New England Journal of Medicine 1991;325:1774-1779. Wutzler P, Sprossig M, Schneider J et al. [A complication after oral protective immunization against poliomyelitis] Komplikation nach oraler Poliomyelitis-Schutzimpfung. Padiatrie und Grenzgebiete 1984;23:289-297. Wyatt G. Planning an immunization schedule. Practitioner 1992;236:479-480, 482. Wyatt HV. Poliomyelitis in hypogammaglobulinemics. Journal of Infectious Diseases 1973;128:802-806. Wyatt HV. Provocation poliomyelitis: neglected clinical observations from 1914 to 1950. Bulletin of the History of Medicine 1981;55:543-557. Wyatt HV. Did thalidomide promote poliomyelitis following oral poliovirus vaccination in West Berlin in 1960? Perspectives in Biology and Medicine 1983;27:93-106. Wyatt HV. Injections cripple, injections kill (letter). Journal of the Indian Medical Association 1986;84:193-194. Wyatt HV. Injections and poliomyelitis: what are the risks of vaccine associated paralysis? Developments in Biological Standardization 1986;65:123-128. Wyatt HV. Poliovaccination in the Gambia (letter). Lancet 1987;2:43. Wyatt HV. Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways. Reviews of Infectious Diseases 1990;12:547-556. Wyatt HV. Provocation paralysis (letter). Lancet 1993;341:61-62. Xu ZY, Margolis HS. Determinants of hepatitis B vaccine efficacy and implications for vaccination strategies. Viral Hepatitis in China: Problems and Control Strategies. Monographs in Virology 1992;19:87-98. Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M, Takahashi Y, Sugiura A. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 1990;8:553-557. Yamauchi T, Wilson C, St. Geme JW. Transmission of live, attenuated mumps virus to the human placenta. New England Journal of Medicine 1974;290:710-712. Yanagi Y, Cubitt BA, Oldstone MB A. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 1992;187:280-289. Yap I, Guan R, Chan SH. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity. Vaccine 1992;10:439-442. Yeoh EK, Chang WK, Ip P, Chan KH, Chan E, Fung C. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers. Journal of Infection 1986;13(Suppl. A):15-18. Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Pediatrics 1990;85(4 Pt 2):690-693.

OCR for page 348
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Yohannan MD, Ramia S, al Frayh AR. Acute paralytic poliomyelitis presenting as Guillain-Barre syndrome. Journal of Infection 1991;22:129-133. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus. New England Journal of Medicine 1979;300:1173-1179. Yoon JW, Eun HM, Essani K, Roncari DA, Bryan LE et al. Possible mechanisms in the pathogenesis of virus-induced diabetes mellitus. [Clinical and Investigative Medicine] Medecine Clinique et Experimentale 1987;10:450-456. Yoon JW, Kim CJ, Pak CY, McArthur RG et al. Effects of environmental factors on the development of insulin-dependent diabetes mellitus. [Clinical and Investigative Medicine] Medecine Clinique et Experimentale 1987;10:457-469. Yoon JW, Onodera T, Notkins AL. Virus-induced diabetes mellitus: XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B-4. Journal of Experimental Medicine 1978;148:1068-1080. Yoon JW, Ray UR et al. Perspectives on the role of viruses in insulin-dependent diabetes. Diabetes Care 1985;8(Suppl. 1):39-44. Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG. Peripheral blood Ia-positive T cells: increases in certain diseases and after immunization. Journal of Experimental Medicine 1980;151:91-100. Yunginger JW. Anaphylaxis. Current Problems in Pediatrics 1992;22:130-147. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. Journal of Infection 1986;13(Suppl. A):39-45. Zaloga GP, Chernow B. Life-threatening anaphylactic reaction to tetanus toxoid. Annals of Allergy 1982;49:107-108. Zevakov VF, Semak SY, Titarenko VI, Andreichenko NV, Gedzul OV. Poliomyelitis viruses in the etiology of aseptic meningitides in Odessa, 1979-1983. Voprosy Virusologii 1987;32:458-464. Zieger B, Basener G, Berdrow J et al. [Vaccinations and complications after vaccination in travellers] Impfungen und Impfkomplikationen bei Auslandsreisenden. Deutsche Gesundheitswesen 1976;31:1956-1958. Zilber N, Rannon L, Alter M, Kahana E. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983;33:1558-1564. Zimmerman B, Gold R, Lavi S. Adverse effects of immunization: is prevention possible? Postgraduate Medicine 1987;82:225-229, 232. Zimmerman RK, Giebink GS. Childhood immunizations: a practical approach for clinicians. American Family Physician 1992;45:1759-1772. Zingher A, Park HW. Immunity results obtained in school children with diphtheria toxoid (modified toxin) with 1/10 L+ mixtures of toxin-antitoxin. Proceedings of the Society for Experimental Biology and Medicine 1923;21:383-385. Zoltowska A. Immunomorphologic patterns in intensively immunized guinea pigs. Archivum Immunologiae et Therapiae Experimentalis 1971;19:417-429. Zoltowska A. Sarcoidal reactions in animals intensively immunized with tetanus vaccine. Archivum Immunologiae et Therapiae Experimentalis 1974;22:341-347. Zwemer R, Hodge S, Owen LG, Fliegelman MT. Persistent toxic erythema and chronic urticaria: possible association with the use of measles virus vaccine. Archives of Dermatology 1971;104:390-392.